Wednesday, September 16, 2026Latest filing Sep 14, 2026

Tina Smith Stock Trades

U.S. Senator · D · MN

Disclosures through May 10

Every stock trade Tina Smith has disclosed under the STOCK Act, parsed by Coldpine. Informational only, sourced from public congressional filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Tina Smith · Sold $DXCM · May 7 · $100K–$250K

0.72HIGH
Disclosure speedx 0.251.00
Trade sizex 0.250.75
Cluster activityx 0.150.70

2 other members traded this name in the same window.

Track recordx 0.35default0.50

Coldpine’s read

Smith's Finance Committee seat carries jurisdiction over healthcare and Medicare policy that touches medical-device makers like DexCom. The spouse-owned sale of $100K–$250K clears at the higher end of typical disclosed ranges. Two other members sold DXCM in the same direction within 30 days, and the 3-day disclosure lag means the market has had limited time to absorb the filing.

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Tina Smith

Get an email the moment Tina Smith discloses a new trade. Free, no card, no spam.

Follow free →
8
Disclosed trades
0
Buys
8
Sells
4
Unique tickers

Most-traded tickers

Recent filingsAll filings, newest first

Recent disclosed trades

DateTickerAssetTypeAmount
May 7DXCMDexCom, Inc. - Common Stocksell$100K–$250K
May 7PODDInsulet Corporation - Common Stocksell$100K–$250K
Apr 29DXCMDexCom, Inc. - Common Stocksell$100K–$250K
Apr 29PODDInsulet Corporation - Common Stocksell$100K–$250K
Mar 31BRK.BBerkshire Hathaway Inc. New Common Stocksell$100K–$250K
Mar 31MMM3M Company Common Stocksell$50K–$100K
Jan 27MRSH - Marsh & McLennan Companies, Inc. Common Stocksell$50K–$100K
Jan 27BRK.BBerkshire Hathaway Cl Bsell$100K–$250K

From Coldpine Research

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →